InSilico Bags Significant AI Lab Collaboration Contract; Shares Rise 4%
MT Newswires Live
Sep 21
InSilico Medicine (HKG:3696) said Monday it will collaborate with an unnamed AI lab to develop frontier models to support biological research under a contract valued at up to tens of millions of U.S. dollars, according to a same-day filing with the bourse.
The duo will leverage InSilico's MMAI Gym training framework and data from its previous scientific studies, and will share revenue under the terms of their agreement, which the company did not disclose.
InSilico's shares were last up 4% on the HKEX.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.